Treatment for dupuytren's disease
First Claim
Patent Images
1. A method for treating a patient with early disease state Dupuytren'"'"'s disease comprising injecting an amount of a TNF-α
- antagonist effective to treat the patient directly into one or more clinical or histological nodules of the patient.
2 Assignments
0 Petitions
Accused Products
Abstract
Musculoskeletal fibroproliferative disorders, such as Dupuytren'"'"'s disease may be treated by administering locally a TNF-α antagonist. TNF-α antagonists find particular utility in inhibiting the progression of early disease state Dupuytren'"'"'s disease and other musculoskeletal fibroproliferative disorders and, in combination with extracellular matrix degradation agents (such ascollagenase or matrix metalloproteinase I), treating advanced disease state Dupuytren'"'"'s disease and, in particular inhibiting recurrence.
-
Citations
9 Claims
-
1. A method for treating a patient with early disease state Dupuytren'"'"'s disease comprising injecting an amount of a TNF-α
- antagonist effective to treat the patient directly into one or more clinical or histological nodules of the patient.
- View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
Specification